179 related articles for article (PubMed ID: 11030348)
1. Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2.
Schwaller J; Parganas E; Wang D; Cain D; Aster JC; Williams IR; Lee CK; Gerthner R; Kitamura T; Frantsve J; Anastasiadou E; Loh ML; Levy DE; Ihle JN; Gilliland DG
Mol Cell; 2000 Sep; 6(3):693-704. PubMed ID: 11030348
[TBL] [Abstract][Full Text] [Related]
2. Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes.
Schwaller J; Frantsve J; Aster J; Williams IR; Tomasson MH; Ross TS; Peeters P; Van Rompaey L; Van Etten RA; Ilaria R; Marynen P; Gilliland DG
EMBO J; 1998 Sep; 17(18):5321-33. PubMed ID: 9736611
[TBL] [Abstract][Full Text] [Related]
3. Constitutively active STAT5 variants induce growth and survival of hematopoietic cells through a PI 3-kinase/Akt dependent pathway.
Santos SC; Lacronique V; Bouchaert I; Monni R; Bernard O; Gisselbrecht S; Gouilleux F
Oncogene; 2001 Apr; 20(17):2080-90. PubMed ID: 11360192
[TBL] [Abstract][Full Text] [Related]
4. Myeloproliferative disease induced by TEL-PDGFRB displays dynamic range sensitivity to Stat5 gene dosage.
Cain JA; Xiang Z; O'Neal J; Kreisel F; Colson A; Luo H; Hennighausen L; Tomasson MH
Blood; 2007 May; 109(9):3906-14. PubMed ID: 17218386
[TBL] [Abstract][Full Text] [Related]
5. The Tel-PDGFRbeta fusion gene produces a chronic myeloproliferative syndrome in transgenic mice.
Ritchie KA; Aprikyan AA; Bowen-Pope DF; Norby-Slycord CJ; Conyers S; Bartelmez S; Sitnicka EH; Hickstein DD
Leukemia; 1999 Nov; 13(11):1790-803. PubMed ID: 10557054
[TBL] [Abstract][Full Text] [Related]
6. Induction of myeloproliferative disease in mice by tyrosine kinase fusion oncogenes does not require granulocyte-macrophage colony-stimulating factor or interleukin-3.
Tomasson MH; Williams IR; Li S; Kutok J; Cain D; Gillessen S; Dranoff G; Van Etten RA; Gilliland DG
Blood; 2001 Mar; 97(5):1435-41. PubMed ID: 11222391
[TBL] [Abstract][Full Text] [Related]
7. Fatal myeloproliferation, induced in mice by TEL/PDGFbetaR expression, depends on PDGFbetaR tyrosines 579/581.
Tomasson MH; Sternberg DW; Williams IR; Carroll M; Cain D; Aster JC; Ilaria RL; Van Etten RA; Gilliland DG
J Clin Invest; 2000 Feb; 105(4):423-32. PubMed ID: 10683371
[TBL] [Abstract][Full Text] [Related]
8. Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin.
Li G; Miskimen KL; Wang Z; Xie XY; Tse W; Gouilleux F; Moriggl R; Bunting KD
Leukemia; 2010 Aug; 24(8):1397-405. PubMed ID: 20535152
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
Smit LS; Vanderkuur JA; Stimage A; Han Y; Luo G; Yu-Lee LY; Schwartz J; Carter-Su C
Endocrinology; 1997 Aug; 138(8):3426-34. PubMed ID: 9231797
[TBL] [Abstract][Full Text] [Related]
10. The influence of antisense oligonucleotides against STAT5 on the regulation of normal haematopoiesis in a bone marrow model.
Baśkiewicz-Masiuk M; Paczkowski M; Machaliński B
Cell Prolif; 2004 Jun; 37(3):231-45. PubMed ID: 15144500
[TBL] [Abstract][Full Text] [Related]
11. Constitutive activation of Stat5a by retrovirus integration in early pre-B lymphomas of SL/Kh strain mice.
Tsuruyama T; Nakamura T; Jin G; Ozeki M; Yamada Y; Hiai H
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8253-8. PubMed ID: 12048235
[TBL] [Abstract][Full Text] [Related]
12. A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis.
Couldrey C; Bradley HL; Bunting KD
Blood; 2005 Feb; 105(4):1476-83. PubMed ID: 15498858
[TBL] [Abstract][Full Text] [Related]
13. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia.
Lacronique V; Boureux A; Valle VD; Poirel H; Quang CT; Mauchauffé M; Berthou C; Lessard M; Berger R; Ghysdael J; Bernard OA
Science; 1997 Nov; 278(5341):1309-12. PubMed ID: 9360930
[TBL] [Abstract][Full Text] [Related]
14. Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation.
Frantsve J; Schwaller J; Sternberg DW; Kutok J; Gilliland DG
Mol Cell Biol; 2001 May; 21(10):3547-57. PubMed ID: 11313480
[TBL] [Abstract][Full Text] [Related]
15. Stat5a/b contribute to interleukin 7-induced B-cell precursor expansion, but abl- and bcr/abl-induced transformation are independent of stat5.
Sexl V; Piekorz R; Moriggl R; Rohrer J; Brown MP; Bunting KD; Rothammer K; Roussel MF; Ihle JN
Blood; 2000 Sep; 96(6):2277-83. PubMed ID: 10979977
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow transplant completely rescues hematolymphoid defects in STAT5A/5B-deficient mice.
Snow JW; Abraham N; Ma MC; Goldsmith MA
Exp Hematol; 2003 Dec; 31(12):1247-52. PubMed ID: 14662331
[TBL] [Abstract][Full Text] [Related]
17. TEL-Syk fusion constitutively activates PI3-K/Akt, MAPK and JAK2-independent STAT5 signal pathways.
Kanie T; Abe A; Matsuda T; Kuno Y; Towatari M; Yamamoto T; Saito H; Emi N; Naoe T
Leukemia; 2004 Mar; 18(3):548-55. PubMed ID: 14749700
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia.
Liu Q; Schwaller J; Kutok J; Cain D; Aster JC; Williams IR; Gilliland DG
EMBO J; 2000 Apr; 19(8):1827-38. PubMed ID: 10775267
[TBL] [Abstract][Full Text] [Related]
19. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
Nyga R; Pecquet C; Harir N; Gu H; Dhennin-Duthille I; Régnier A; Gouilleux-Gruart V; Lassoued K; Gouilleux F
Biochem J; 2005 Aug; 390(Pt 1):359-66. PubMed ID: 15833084
[TBL] [Abstract][Full Text] [Related]
20. Enforced activation of STAT5A facilitates the generation of embryonic stem-derived hematopoietic stem cells that contribute to hematopoiesis in vivo.
Schuringa JJ; Wu K; Morrone G; Moore MA
Stem Cells; 2004; 22(7):1191-204. PubMed ID: 15579639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
